Dr. Jay Bhaumik’s career as a pharmacy executive has exposed him to enough patients who abandon otherwise effective treatment plans to show that prescribing the right medications is only part of effective patient care. Getting each patient to take their prescribed medication consistently and as directed can be the harder bit.
An unfilled prescription or skipped doses can deliver no clinical benefit, no matter how well the medication was chosen. Solving the challenge becomes easier when we acknowledge that compounding pharmacies occupy a specific, often overlooked, role in helping patients adhere to medication schedules. While many medical care providers treat adherence as a behavioral concern to be managed, compounding addresses root causes directly at the prescription level.
The Scope of Medication Nonadherence in American Healthcare
Nonadherence is, by most measures, the norm as opposed to the exception in medication usage. Roughly half of all medications prescribed for chronic conditions are not taken as directed, and nonadherence has been linked to approximately 125,000 preventable deaths annually, along with tens of billions of dollars in avoidable healthcare spending each year.
The reasons behind that gap are varied and span cost, forgetfulness, confusion regarding complex regimens, and medications that patients just find difficult to tolerate or administer. What unites many of these reasons is that they are structural, not personal failings, meaning that in many cases they can be engineered out of the prescription itself.
Pill Burden and the Case for Consolidated Dosing
Patients managing multiple chronic conditions commonly juggle five, ten, or more separate medications, each with its own schedule, food requirements, and storage instructions. Such complexity, known as pill burden, is one of the most consistent predictors of poor adherence.
Research reviewing dozens of studies has shown that adherence improves significantly when multiple medications are consolidated into a single formulation compared with taking the same drugs separately.
Compounding pharmacies are uniquely positioned to address the obstacle for patients whose regimens do not fit a commercially manufactured combination product. A pharmacist can consolidate compatible medications into a single capsule or dosing schedule tailored to what a specific patient is actually taking, an option unavailable through standard retail dispensing.
New and recent formulation science has expanded this further, with modular approaches to polypill design allowing individual drug doses within a combined formulation to be adjusted without rebuilding the entire regimen from scratch.
“Every pill a patient has to remember, sort, and take separately is another opportunity for the regimen to fall apart. Consolidating what can safely be consolidated is often the difference between a patient staying on therapy and quietly drifting off it,” says Dr. Jay Bhaumik, Chairman of Thesis Compounding Pharmacy.
Taste, Texture, and the Barriers Patients Don’t Talk About
Patients seldom tell their prescriber that they stopped a medication because it tasted unbearable; taste is one of the most underdiscussed drivers of discontinuation. A striking share of active pharmaceutical ingredients carry an inherently bitter profile, and studies indicate that a substantial percentage of patients are at meaningful risk of abandoning treatment because of how poorly a medication tastes rather than how well it works.
Pediatric populations face this barrier most acutely, and researchers examining caregiver and provider perspectives on unpalatable pediatric medicines have found taste to be a primary reason children refuse or spit out prescribed doses. Compounding pharmacies routinely resolve this through flavoring and texture modification unavailable in commercial products, transforming a formulation a patient physically cannot tolerate into one they can.
Adults managing chronic conditions long-term encounter a quieter version of the same problem, where a slightly unpleasant but tolerable taste, repeated daily for years, gradually erodes willingness to continue.
“Nobody stops a medication and writes ‘bad taste’ as the official reason, but ask enough patients directly, and it comes up constantly. It’s one of the most fixable problems in all of pharmacy, and it goes unfixed far too often,” says Dr. Bhaumik.
Compounding as a Bridge Through Side Effects and Intolerance
Side effects drive discontinuation in ways that surpass taste alone. A patient who develops a rash from an inactive dye, gastrointestinal upset from a filler, or systemic effects from a dose that is technically correct but individually too strong faces the same choice. Patients can tolerate a treatment that is actively working against them or abandon it altogether.
Standard commercial formulations offer no middle path, since the strength, inactive ingredients, and delivery method are fixed at the point of manufacture. Compounding removes that binary, so a pharmacist can eliminate a specific allergen, adjust strength incrementally to find the lowest effective dose, or even switch delivery methods entirely. Patients who might otherwise discontinue therapy altogether are given a version of the same treatment that their body can sustain.
Building Adherence into the Prescription Itself
There is a throughline across pill burden, taste, and tolerability, as each represents a point where commercially manufactured medication demands that the patient adapt to the product. Compounding inverts that relationship, and the prescription is built around the patient’s physiology, preferences, and daily routine as opposed to a population average.
“Adherence conversations usually focus on reminders and pillboxes, and those tools have their place. But if the medication itself is hard to take, no reminder system fixes that. Sometimes the most effective adherence intervention is simply making the prescription easier to take in the first place,” says Dr. Bhaumik.
What Staying on Treatment Actually Requires
One is suggesting compounding solves nonadherence on its own, as cost, health literacy, and access to care are significant and separate barriers that formulation changes cannot address. Compounding offers a genuine answer to the substantial share of nonadherence rooted in the physical experience of taking a medication.
Treatment plans work when a patient can sustain them, and sustaining a regimen depends on if the medication fits into a life the patient is living day after day, without becoming a burden they eventually decide to set down.
